Earnings call transcript: Kura Oncology Q1 2026 revenue miss overshadows stable EPS

Forms & Filings Investing.com By Investing.com 18 May 2026 13:08 1 min read

Earnings call transcript: Kura Oncology Q1 2026 revenue miss overshadows stable EPS

Earnings call transcript: Kura Oncology Q1 2026 revenue miss overshadows stable EPS

Earnings call transcript: Kura Oncology Q1 2026 revenue miss overshadows stable EPS

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.